Advertisement
YOU ARE HERE: LAT HomeCollections5 Fu Drug
IN THE NEWS

5 Fu Drug

FEATURED ARTICLES
NEWS
April 19, 1990 | SHAWN POGATCHNIK, TIMES STAFF WRITER
A third of the approximately 50,000 Americans who die each year from post-surgery recurrences of colon cancer could enjoy longer lives if they received a newly approved chemotherapy technique, a panel of medical experts meeting at the National Institutes of Health said Wednesday.
ARTICLES BY DATE
NEWS
April 19, 1990 | SHAWN POGATCHNIK, TIMES STAFF WRITER
A third of the approximately 50,000 Americans who die each year from post-surgery recurrences of colon cancer could enjoy longer lives if they received a newly approved chemotherapy technique, a panel of medical experts meeting at the National Institutes of Health said Wednesday.
Advertisement
NEWS
October 3, 1989 | MARLENE CIMONS, Times Staff Writer
New research shows that a combination of two drugs given after surgery substantially reduces the death rate for patients with advanced colon cancer, the National Cancer Institute announced Monday. "This is a major advance," Dr. Samuel Broder, director of the cancer institute, said at a press conference. "The results suggest we might be able to reduce the death rate by as much as one-third."
NEWS
October 3, 1989 | MARLENE CIMONS, Times Staff Writer
New research shows that a combination of two drugs given after surgery substantially reduces the death rate for patients with advanced colon cancer, the National Cancer Institute announced Monday. "This is a major advance," Dr. Samuel Broder, director of the cancer institute, said at a press conference. "The results suggest we might be able to reduce the death rate by as much as one-third."
BUSINESS
March 18, 1986 | CARLA LAZZARESCHI
International Pharmaceutical Products Inc. of Costa Mesa said Monday it has received Food and Drug Administration approval to sell a generic form of an anti-cancer drug that has been on the market for years. The drug, 5-Fluorouracil (5-FU) Injection, was developed originally by Hoffman--LaRoche & Co., the Swiss drug firm, as a chemotherapy treatment for cancers of the colon, rectum, breast, stomach and pancreas.
Los Angeles Times Articles
|